121 related articles for article (PubMed ID: 2399726)
1. [The metabolic and phagocytic activities of the neutrophilic granulocytes in patients with nonspecific ulcerative colitis nd Crohn's disease].
Blazhenko IL; Bychkova NG; Shvets NI
Vrach Delo; 1990 Jun; (6):61-2. PubMed ID: 2399726
[TBL] [Abstract][Full Text] [Related]
2. [The dynamic phagocytic and metabolic activities of the neutrophilic granulocytes in patients with nonspecific ulcerative colitis and Crohn's disease under the influence of immunocorrective therapy].
Blazhenko IL; Kucher ND
Vrach Delo; 1991 Jan; (1):70-2. PubMed ID: 2011899
[No Abstract] [Full Text] [Related]
3. Release of leukotriene B4 and 5-hydroxyeicosatetraenoic acid during phagocytosis of artificial immune complexes by peripheral neutrophils in chronic inflammatory bowel disease.
Nielsen OH; Elmgreen J; Thomsen BS; Ahnfelt-Rønne I; Wiik A
Clin Exp Immunol; 1986 Aug; 65(2):465-71. PubMed ID: 3024887
[TBL] [Abstract][Full Text] [Related]
4. Enhanced superoxide anion release of normal neutrophil granulocytes primed with sera of patients with inactive inflammatory bowel disease.
Griga T; Tromm A; Schwegler U; May B
Z Gastroenterol; 1995 Jul; 33(6):345-8. PubMed ID: 7668025
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
[TBL] [Abstract][Full Text] [Related]
8. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
Lyanga J; Davis P; Thomson AB
West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
[TBL] [Abstract][Full Text] [Related]
9. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
Schmitz-Moormann P; Himmelmann GW; Brandes JW
Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
[TBL] [Abstract][Full Text] [Related]
10. Indices of granulocyte activity in ulcerative colitis and Crohn's disease.
Koldkjaer O; Klitgaard NA; Schmidt KG
Dan Med Bull; 1977 Apr; 24(2):72-6. PubMed ID: 852316
[No Abstract] [Full Text] [Related]
11. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
Rhodes JM; Potter BJ; Brown DJ; Jewell DP
Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
[TBL] [Abstract][Full Text] [Related]
12. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
14. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
Folwaczny C; Wiebecke B; Loeschke K
Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
[TBL] [Abstract][Full Text] [Related]
15. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis.
Wandall JH
Scand J Gastroenterol; 1985 Nov; 20(9):1151-6. PubMed ID: 4089525
[TBL] [Abstract][Full Text] [Related]
16. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
[TBL] [Abstract][Full Text] [Related]
17. Enhanced metabolic activity by polymorphonuclear leukocytes from patients with active inflammatory bowel disease.
Lamster IB; Sonis ST; Wilson RE; Falchuk ZM
Surg Forum; 1979; 30():362-4. PubMed ID: 538634
[No Abstract] [Full Text] [Related]
18. [Treatment with total parenteral nutrition in inflammatory diseases of the intestine].
Mingolla F; Cavicchi A; Feliciotti F; Caputi CA; Braccioni U
Chir Ital; 1983 Dec; 35(6):885-97. PubMed ID: 6441650
[TBL] [Abstract][Full Text] [Related]
19. [The effect of hemosorption on the glycoprotein concentration of the blood serum in inflammatory diseases of the large intestine].
Ivanov AF; Eroshkina TD; Fomin SA; Musin II; Chirkin VV
Ter Arkh; 1995; 67(2):36-9. PubMed ID: 7536960
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
